Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) - Investment analysts at William Blair raised their Q3 2025 earnings estimates for Celsius in a research note issued on Tuesday, April 1st. William Blair analyst J. Andersen now anticipates that the company will post earnings of $0.29 per share for the quarter, up from their previous estimate of $0.23. The consensus estimate for Celsius' current full-year earnings is $0.89 per share. William Blair also issued estimates for Celsius' Q4 2025 earnings at $0.27 EPS and FY2025 earnings at $1.04 EPS.
CELH has been the subject of a number of other research reports. Piper Sandler dropped their price target on Celsius from $47.00 to $33.00 and set an "overweight" rating for the company in a research report on Thursday, January 23rd. Jefferies Financial Group dropped their target price on shares of Celsius from $44.00 to $40.00 and set a "buy" rating for the company in a research report on Thursday, December 19th. B. Riley reissued a "buy" rating and issued a $49.00 price target (up previously from $44.00) on shares of Celsius in a research note on Friday, February 21st. LADENBURG THALM/SH SH lowered their price objective on shares of Celsius from $62.00 to $58.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. Finally, Roth Mkm reiterated a "buy" rating and issued a $38.00 target price on shares of Celsius in a research report on Friday, February 21st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, Celsius has an average rating of "Moderate Buy" and an average price target of $45.00.
Check Out Our Latest Analysis on Celsius
Celsius Stock Down 2.8 %
NASDAQ:CELH traded down $1.00 during trading hours on Thursday, hitting $34.46. 3,115,002 shares of the company's stock traded hands, compared to its average volume of 7,599,918. The firm has a market cap of $8.10 billion, a P/E ratio of 78.50, a P/E/G ratio of 2.90 and a beta of 1.58. The business's fifty day simple moving average is $28.05 and its two-hundred day simple moving average is $28.86. Celsius has a 52 week low of $21.10 and a 52 week high of $98.85.
Celsius (NASDAQ:CELH - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.14 EPS for the quarter, beating analysts' consensus estimates of $0.11 by $0.03. Celsius had a net margin of 10.70% and a return on equity of 51.89%. The firm had revenue of $332.20 million during the quarter, compared to analyst estimates of $326.07 million.
Insiders Place Their Bets
In other Celsius news, Director Joyce Russell sold 4,000 shares of the firm's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total value of $113,880.00. Following the sale, the director now owns 19,106 shares of the company's stock, valued at $543,947.82. This trade represents a 17.31 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Paul H. Storey sold 10,188 shares of the company's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $25.77, for a total transaction of $262,544.76. Following the transaction, the insider now directly owns 45,297 shares of the company's stock, valued at approximately $1,167,303.69. This trade represents a 18.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.20% of the company's stock.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the business. HM Payson & Co. grew its position in shares of Celsius by 122.2% in the 4th quarter. HM Payson & Co. now owns 1,000 shares of the company's stock worth $26,000 after buying an additional 550 shares during the last quarter. MassMutual Private Wealth & Trust FSB boosted its holdings in Celsius by 255.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock valued at $37,000 after acquiring an additional 750 shares in the last quarter. S.A. Mason LLC increased its position in Celsius by 100.0% during the 4th quarter. S.A. Mason LLC now owns 1,400 shares of the company's stock valued at $37,000 after purchasing an additional 700 shares during the period. GAMMA Investing LLC raised its holdings in Celsius by 185.7% in the 4th quarter. GAMMA Investing LLC now owns 1,714 shares of the company's stock worth $45,000 after purchasing an additional 1,114 shares in the last quarter. Finally, Blue Trust Inc. lifted its position in shares of Celsius by 32.8% in the 4th quarter. Blue Trust Inc. now owns 1,786 shares of the company's stock worth $47,000 after purchasing an additional 441 shares during the period. Hedge funds and other institutional investors own 60.95% of the company's stock.
About Celsius
(
Get Free Report)
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Further Reading

Before you consider Celsius, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.
While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.